These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17108059)

  • 1. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.
    Wang Q; Morris ME
    Drug Metab Dispos; 2007 Feb; 35(2):201-8. PubMed ID: 17108059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells.
    Shim CK; Cheon EP; Kang KW; Seo KS; Han HK
    J Pharm Pharmacol; 2007 Nov; 59(11):1515-9. PubMed ID: 17976262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters.
    Wang X; Wang Q; Morris ME
    AAPS J; 2008; 10(1):47-55. PubMed ID: 18446505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells.
    Wang Q; Morris ME
    Drug Metab Dispos; 2007 Aug; 35(8):1393-9. PubMed ID: 17502341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin, Morin, Luteolin, and Phloretin Are Dietary Flavonoid Inhibitors of Monocarboxylate Transporter 6.
    Jones RS; Parker MD; Morris ME
    Mol Pharm; 2017 Sep; 14(9):2930-2936. PubMed ID: 28513167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters.
    Wang Q; Darling IM; Morris ME
    J Pharmacol Exp Ther; 2006 Aug; 318(2):751-61. PubMed ID: 16707723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.
    Cui D; Morris ME
    Drug Metab Dispos; 2009 Jul; 37(7):1404-10. PubMed ID: 19389857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.
    Bhattacharya I; Boje KM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):92-8. PubMed ID: 15173314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells.
    Wang Q; Lu Y; Morris ME
    Pharm Res; 2007 Jun; 24(6):1067-78. PubMed ID: 17377745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of monocarboxylate transport in human kidney HK-2 cells.
    Wang Q; Lu Y; Yuan M; Darling IM; Repasky EA; Morris ME
    Mol Pharm; 2006; 3(6):675-85. PubMed ID: 17140255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19.
    Majumdar S; Gunda S; Pal D; Mitra AK
    Mol Pharm; 2005; 2(2):109-17. PubMed ID: 15804185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.
    Hougee S; Sanders A; Faber J; Graus YM; van den Berg WB; Garssen J; Smit HF; Hoijer MA
    Biochem Pharmacol; 2005 Jan; 69(2):241-8. PubMed ID: 15627476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1.
    Thiesen L; Kehler J; Clausen RP; Frølund B; Bundgaard C; Wellendorph P
    J Pharmacol Exp Ther; 2015 Aug; 354(2):166-74. PubMed ID: 25986445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1.
    Okamura A; Emoto A; Koyabu N; Ohtani H; Sawada Y
    Br J Pharmacol; 2002 Oct; 137(3):391-9. PubMed ID: 12237260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
    Morse BL; Morris ME
    J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γ-Hydroxybutyrate blood/plasma partitioning: effect of physiologic pH on transport by monocarboxylate transporters.
    Morse BL; Felmlee MA; Morris ME
    Drug Metab Dispos; 2012 Jan; 40(1):64-9. PubMed ID: 21976619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate.
    Morse BL; Vijay N; Morris ME
    AAPS J; 2014 Jul; 16(4):756-70. PubMed ID: 24854892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability.
    Galić S; Schneider HP; Bröer A; Deitmer JW; Bröer S
    Biochem J; 2003 Dec; 376(Pt 2):413-22. PubMed ID: 12946269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid.
    Rodriguez-Cruz V; Ren T; Morris ME
    Biopharm Drug Dispos; 2021 Sep; 42(8):351-358. PubMed ID: 34191301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Drug of Abuse Gamma-Hydroxybutyric Acid Exhibits Tissue-Specific Nonlinear Distribution.
    Felmlee MA; Morse BL; Follman KE; Morris ME
    AAPS J; 2017 Dec; 20(1):21. PubMed ID: 29280004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.